MIR192 upregulates GLP-1 receptor and rescues statin-induced impairment of insulin secretion
Statins are a commonly prescribed cholesterol-lowering drug class that can increase the risk of new-onset diabetes (NOD). The underlying molecular mechanisms have yet to be fully elucidated. We aimed to identify molecular factors associated with differential susceptibility to NOD and determine their effects on β-...
Yu-Lin Kuang, C. Locatelli, Yu-Qing Zhang et al.
· Cardiovascular Diabetology · 0 citations